Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia.

Lukas Weiss; Thomas Melchardt; Alexander Egle; Christoph Grabmer; Richard Greil; Inge Tinhofer

doi:10.1002/cncr.25752

Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia.

Lukas Weiss (Erstautor/-in), Thomas Melchardt (Co-Autor/-in), Alexander Egle (Co-Autor/-in), Christoph Grabmer (Co-Autor/-in), Richard Greil^* (Co-Autor/-in), Inge Tinhofer

^*Korrespondierende/r Autor/-in für diese Arbeit

Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

51 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	2163-2169
Fachzeitschrift	CANCER
Jahrgang	117
Ausgabenummer	10
DOIs	https://doi.org/10.1002/cncr.25752
Publikationsstatus	Veröffentlicht - 2011

Zugriff auf Dokument

10.1002/cncr.25752

Dieses zitieren

@article{193052bcae4f4f9dbe37516a9e63269f,

title = "Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia.",

keywords = "GENE MUTATION STATUS, SUPPRESSIVE FUNCTION, TRANSGENIC MICE, B-CELLS, EXPRESSION, CANCER, SURVIVAL, RECEPTORS, DISEASE, CLL",

author = "Lukas Weiss and Thomas Melchardt and Alexander Egle and Christoph Grabmer and Richard Greil and Inge Tinhofer",

note = "Richard Greil, MD, Laboratory for Immunological and Molecular Cancer Research (LIMCR), Third Medical Department With Hematology, Medical Oncology, Hemostaseology, Rheumatology, and Infectious Disease of the Private Medical University Hospital Salzburg, Muellner Hauptstrasse 48, 5020 Salzburg, Austria;",

year = "2011",

doi = "10.1002/cncr.25752",

language = "English",

volume = "117",

pages = "2163--2169",

journal = "CANCER",

issn = "0008-543X",

publisher = "Wiley Verlag ",

number = "10",

}

TY - JOUR

T1 - Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia.

AU - Weiss, Lukas

AU - Melchardt, Thomas

AU - Egle, Alexander

AU - Grabmer, Christoph

AU - Greil, Richard

AU - Tinhofer, Inge

N1 - Richard Greil, MD, Laboratory for Immunological and Molecular Cancer Research (LIMCR), Third Medical Department With Hematology, Medical Oncology, Hemostaseology, Rheumatology, and Infectious Disease of the Private Medical University Hospital Salzburg, Muellner Hauptstrasse 48, 5020 Salzburg, Austria;

PY - 2011

Y1 - 2011

KW - GENE MUTATION STATUS

KW - SUPPRESSIVE FUNCTION

KW - TRANSGENIC MICE

KW - B-CELLS

KW - EXPRESSION

KW - CANCER

KW - SURVIVAL

KW - RECEPTORS

KW - DISEASE

KW - CLL

U2 - 10.1002/cncr.25752

DO - 10.1002/cncr.25752

M3 - Original Article

C2 - 21523729

SN - 0008-543X

VL - 117

SP - 2163

EP - 2169

JO - CANCER

JF - CANCER

IS - 10

ER -